SLIMALUMA HOME
CARALLUMA FIMBRIATA
HUMAN CLINICAL STUDIES
SAFETY STUDIES
CELL LINE AND FAT LOSS STUDY
CERTIFICATIONS FOR SLIMALUMA
SLIMALUMA ANTI-CELLULITIS STUDY
ARTICLES IN PRESS ABOUT SLIMALUMA
 
 
     
     
  In-Vitro and In-Vivo studies were done to understand the mechanism of action of Slimaluma.  
     
 
1. The In-Vitro study showed that Slimaluma seems to reduce differentiation of adipocytes and
  reduce adipose tissue formation, thereby reducing abdominal adiposity. This effect validated
  the statistically significant reduction of waist circumference seen in the published human
  clinical study.
2. The In-Vivo study showed that Slimaluma reduces hunger, reduces weight gain, reduces
  Leptin levels and clears clogged arteries. The study was published in the Journal of Nutrition
  and Metabolism (2010. DOI:10.1155/2010/285301).
   
  References :
1. Effect of Caralluma fimbriataextract on 3T3-L1 pre-adipocyte cell division. Kamalakannan et.
  Al., under publication.
2. Journal of Nutrition and Metabolism, Hindawi Publishing Corporation
  Volume 2010, Article ID 285301, 6 pages
  DOI: 10.1155/2010/285301
   
 
  Antiobesigenic and antiatherosclerotic properties of Caralluma fibriata extract  
     
  Authors: Soundararajan Kamalakkannan, Ramaswamy Rajendran, Ramasamy V. Venkatesh, Paul Clayton, and Mohammad A. Akbarsha  
PRODUCTS
 
 
 
 
 
 
 
 
 
LOCATIONS
 
INDIA
 
UNITED STATES
 
HONG KONG
 
CHINA
 
BAHRAIN
 
UAE
 
QATAR